Objective. The study were undertaken to evaluate anti-fibrotic activity of ethanolic extract of Nelumbo nucifera seed (NNSEE) against doxorubicin and Unilateral Ureter Obstruction-induced renal fibrosis. Materials and method. Animals were divided into five groups with six animals in each group, i.e. Normal, Positive control, Standard (Pirfenidone 200mg/kg), Test-I (NNSEE 200mg/kg), and Test-II (NNSEE 400mg/kg). Renal fibrosis was developed by doxorubicin and UUO-induced methods. After induction of renal fibrosis, profibrotic responses in biochemical parameters were observed, e.g. BUN, serum creatinine levels were elevated, while total protein and GFR levels decreased. Antioxidant (SOD and CAT) levels are also attenuates and hyalinized glomeruli cells, damage to tubular cells were noted in histopathology, which are all responsible for the development of renal fibrosis. Results. The result showed that the anti-fibrotic activity of NNSEE at a dose of 200 and 400mg/kg b.wt was comparable with the standard treatment 200mg/kg b.wt of pirfenidone (anti-fibrotic drug). These data supplemented with histopathological studies of rat kidney sections. NNSEE had reversed all the manifestation of renal fibrosis. Conclusion. Results of the study indicate that the NNSEE has potent anti-fibrotic activity, as well as antioxidant property, in dose dependent manner that may be due to the presence of major phytochemical constituents such as alkaloids, polyphenols.
INTRODUCTION
For human beings, health is most important from birth to end of life, but from the past to the present man has been suffering from diseases. Although global modernization has bought about a revolutionary change in the field of medicine for diagnosis, treatment and understanding disease, but the present day sophisticated life style, food habits, nature of work, etc. are leading to a number of life-threatening diseases. Nowadays, renal fibrosis has become one of the most problematic diseases has been suffering throughout the world.
Renal fibrosis occurs when the normal tissue architecture is slowly taken place by an extracellular matrix (ECM). Fibrosis of both glomerular and tubulointerstitial compartments correlates with diminishing renal function in all progressive forms of diabetic and non-diabetic glomerular disease which leads to end-stage renal disease. Renal fibrosis is characterized by the excessive deposition of connective tissue and organ inflammation. Literature reviews by the authors of the presented study suggest that the main reason for renal fibrosis has revealed a close relationship between the expression of TGF-β and cytokine. TGF-β is predominantly present in human umbilical vein endothelial cells. The main role of TGF-β is increasing the ECM protein synthesis, fibronectin, and also promote the accumulation of ECM. It was revealed recently that the TGF-β expression is upregulated in proliferative and fibrotic glomerular lesions in various humans and experimental nephropathies, glomerulonephritis and diabetic nephropathy [1] . This condition impacts on millions of people worldwide and can lead to the deterioration of the kidney, which leads to death. In fact, about 40% of all deaths due to kidney failure are linked to fibrosis. Kidney fibrosis typically occurs in every type of CKD, a medical condition characterized by the gradual loss of kidney function over time [2] . Allopathic medications are safe and efficacious, but prolonged usage may cause disabling side-effects. In order to remedy this kind of condition, using the herbal medicine is very effective, rather than the allopathic drugs.
The World Health Organization (WHO) reports that 80% of the world population presently use herbal medicine for initial health care. During the past few decades, the affinity for herbal drugs has grown by the utilization of traditional medicinal plants to heal some critical diseases. It is proving to be better medicine with respect to synthetic drugs that assure numerous side-effects by long-term therapy. In recent years, focus on plant research has increased worldwide. A large body of evidence has been collected that shows the immense potential of medicinal plants used in various traditional systems [3] .
Although there are many plants like Apiumgraveolens, Boerhaviadiffusa, Phyllanthusniruri, Datura metal which have medicinal properties, Hibiscus sabdariffaetc has a nephroprotective property which has been proved scientifically.
Plant extraction.
The collected dried seeds of Nelumbo nucifera were cleaned and powdered in a grinding mill. The seed powder was shaken in 44-mesh sieve for the coarse fined powder. The fined powder was stored in airtight container at room temperature until preparation of extract. In the extraction process, two solvents were used -petroleum ether and ethanol. The fine-powdered drug was subjected to extraction of petroleum ether solvent in 1:4 ratios (w/v), by using Soxhlet apparatus for 12 hours to remove fat material, and the marc was reused for extraction with 70% ethanol at 40°C. The extraction was carried out until the extract becames colourless. Extract was concentrated, dried and packed in an air-tight container. The obtained semi-solid extract of Nelumbo nucifera seed was used for animal studies and phytochemical screening, stored at a cool temperature of 2-4°C, throughout the duration of the study [ Acute toxicity studies. An acute toxicity study was carried out to demonstrate the appropriate safe dose range that could be used for subsequent experiments rather than to provide complete toxicity data on the extract. As per the OECD 423 Guidelines, Wistar albino rats (180-200g) were used for the toxicity studies. Healthy rats were randomly assigned to 4 groups with 3 rats in each group. Rats were administered with NNSEE of 5, 50, 300 and 2,000mg/kg, b.wt. Signs or symptoms of acute toxicity and mortality rate were observed continuously for the first 4 h, followed by 24 h, and further observation prolonged for up to 14 days.
METHODOLOGY

Doxorubicin inducing method
Body system. Antineoplastic and Immunomodulating agents. Schedule: Chemotherapy type. Doxorubicin hydrochloride 10mg/5ml injection, 5 ml vial. Doxorubicin hydrochloride 50mg/25ml injection, 25 ml vial. Doxorubicin hydrochloride 100mg/50ml injection, 50 ml vial.
Animals are injected intravenously with a single dose of doxorubicin 4 mg/kg. The rate of renal damage and development of fibrosis increases with the increase in doxorubicin dose. To examine the extent of disease, this can be stratified on the basis of the proteinuria levels. The renal damage starts after 1-2 weeks and progresses continuously for several weeks. During this period of time, renal functions drop and ECM proteins gradually accumulate in the glomeruli and tubulointerstitium.
At the end of the studied time, the animals were sacrificed and the kidneys are examined for tubular injury, inflammation and fibrosis using histopathological analysis. Biochemical parameter such as glomerular filtration rate, serum creatinine, blood urea nitrogen (BUN) and total protein levels were assess. This model was also used to evaluate with Pirfenidone (200mg/kg b.wt, p.o) and NNSEE.
Unilateral ureter obstruction method. Animals were anesthetized with general anesthesia with ketamine chloride (50mg/kg b.wt i.p). The left kidney was exposed via flank incision and the ureter ligated with silk suture (i.e 4-0) for reliable ligation. Abdominal muscle and skin were stitched separately, layer-by-layer. Renal fibrosis was visible on day 3 at the earliest, and extensive fibrosis occured after 2-3 weeks.
This animal model was from 3 days to 21 days, but 14 days is an optimum time for testing anti-fibrotic drugs. At the end of the studied time point, the animals were sacrificed and the kidneys are examined for tubular injury, inflammation and fibrosis, using histopathological analysis. Biochemical parameters like glomerular filtration rate, serum creatinine, blood urea nitrogen (BUN) and total protein levels were assess. This model has been used to evaluate with Pirfenidone (200mgkg, b.wt) and NNSEE [5] . Histopathology. Kidney tissues were fixed in 10% formalin for at least 24 hours, embedded in paraffin and cut into 3μm thick sections in rotary microtome. The section was stained withhematoxylin and eosin, observed under a microscope to detect histopathological changes in the kidney and photographs were taken.
Statistical analysis.
Results were presented as mean ± SEM (n=6). The data was statistically analysed by One-way analysis of variance (ANOVA), followed by Dunnett's multiple comparison tests (t test) and a P< 0.05, b P< 0.01, c P< 0.001 were considered as significant, P>0.05 was considered as nonsignificant (ns) which was compared with positive control. All statistical analyses were performed with Graphpad Prism software application (7.01version).
RESULTS
Priliminary phytochemical test
More phytochemical constituents are present in NNSEE (alkaloids, flavonoids, tannins, saponins, carbohydrates, phenols, glycosides, proteins and amino acids) than in the Pet. ether extract. Therefore, in the subsequent studies NNSEE was used because it may show better therapeutic efficacy than the petroleum ether extract due to the presence of most of the biochemical constituents.
Acute toxicity studies
The animals were observed individually after administration of NNSEE, at first 6 hours periodically during the first 24 hours, and thereafter daily for a total 14 days. There was no Graph 1 shows the serum creatinine level (mg/dL) among different groups (n=6), compared with positive control (#). Doxorubicin-induced in the rats resulted in a signifcant increase in serum creatinine level, compared with normal group. Elevated creatinine level may lead to one of the reasonable profibrotic responses. Rats were then treated with standard Pirfenidone (200mgkg, b.wt) and NNSEE (200mg/ kg and 400mg/kg), which attenuates the profibrotic responses. NNSEE and pirfenidone, which ameliorates renal dysfunction in rats against doxorubicin-induced renal fibrosis. Finally, it was observed that the test-2 of NNSEE showed better results than the test-1. Graph 2 shows that the BUN level (mg/dL) among different groups (n=6) compared with positive control (#). In this estimation, when compared with the normal group, the BUN level had increased in doxorubicin-induced rats. The abnormal BUN level may result in profibrotic responses. Rats were then treated with standard (Pirfenidone 200mg/kg)and NNSEE (200mg/kg and 400mg/kg), which attenuates the elevated BUN levels. NNSEE and pirfenidone ameliorates renal dysfunction in rats with doxorubicin-induced renal fibrosis. Finally, it was observed that the test-2 dose of NNSEE showed better results than the test-1.
Graph 3 shows the total protein level (g/dL) among different groups (n=6) compared with positive control (#). Total protein levels were decreased in doxorubicin-induced rats when compared with normal group. Reduced levels of total protein content may lead to profibrotic responses. The rats were next treated with standard(Pirfenidone 200mg/kg) and NNSEE (200mg/kg and 400mg/kg), which ameliorates the decreased levels of total protein. NNSEE and pirfenidone ameliorate renal dysfunction in rats with doxorubicininduced renal fibrosis. Finally, it was observed that the test-2 dose of NNSEE showed better results than the test-1. and 400mg/kg) which attenuates the elevated levels indicatig anti-fibrosis activity. NNSEE and pirfenidone ameliorate renal dysfunction in rats against UUO-induced renal fibrosis. Finally, it was noticed that the test-2 dose of NNSEE showed better results than the test-1. NNSEE and pirfenidone ameliorates renal dysfunction in rats with UUO induced renal fibrosis. Finally, it was observed that the test-2 dose of NNSEE showed better results than the test-1.
Graph 7 shows the total protein level (g/dL) among different groups (n=6) compared with positive control (#) in UUO-induced rats when compared with the normal group. Abnormal levels of total protein content may lead to a profibrotic response. Rats were then treated with standard (Pirfenidone 200mg/kg) and NNSEE (200mg/kg and 400mg/kg) which ameliorates the decreased levels, indicating anti-fibrotic activity. NNSEE and pirfenidone ameliorates renal dysfunction in rats with UUO-induced renal fibrosis. Finally, it was noted that the test-2 dose of NNSEE showed better results than the test-1. Graph 8 shows the GFR level (mL/min/1.73m
2 ) among different groups (n=6) compared with positive control (#). When compared with the normal group, GFR level signifcantly decreased in UUO-induced rats. An abnormal GFR level in urine indicated renal dysfuntion which may lead to fibrosis. Rats were then treated with standard (Pirfenidone 200mg/kg) and NNSEE (200mg/kg and 400 mg/kg) which ameliorates the GFR levels. NNSEE and pirfenidone(standard drug) ameliorates renal fibrosis in rats, which indicates antifibrotic activity. Finally, it was noted that the test-2 dose of NNSEE showed better results than the test-1. of Superoxide dismutase (SOD) enzyme (scavenger of free radicals) in doxorubicin-induced rats was investiated. Free radicals are responsible for the profibrotic responses. In the positive control group, the SOD enzymes decreased, i.e superoxides were elevated, compared to the normal group followed by the remaining groups. Treating the rats with standard (Pirfenidone 200mg/kg) and NNSEE extract (200 and 400mg/kg b.wt) increases the SOD enzyme which attenuates free radical activity. NNSEE and pirfenidone ameliorates renal fibrosis in doxorubicin-induced rats, indicating anti-fibrotic activity dose dependently. Finally, it was observed that test-2 of NNSEE (400mg/kg b.wt) showed better therapeutic action than the test-1 (200mg/kg b.wt).
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Graph 10 shows the CAT (units/mg protein) level among different groups (n=6) compared with the positive control group (#). The presented study investigated the antioxidant acitvity of catalase (CAT) enzyme (scavenger of free radicals) in UUO-induced rats. Free radicals are responsible for the profibrotic responses. In the positive control group, the catalse enzyme decreased compared to the normal group. Treating the rats with standard (Pirfenidone 200mg/kg) and NNSEE extract (200 and 400mg/kg b.wt) increased the catalase enzyme which attenuates free radical activity. NNSEE and pirfenidoneameliorates renal fibrosis in rats against UUO-induced rats indicated anti-fibrotic activity dose dependently. Ultimately, noticed that test-2 of NNSEE (400mg/kg b.wt) has shown better therapeutic action than the test-1 (200mg/kg b.wt). UUO-induced kidney injury can lead to progressive renal fibrosis. In the presented study, hyalinized glomeruli cells or scar formation occuring in the kidney was assessed by Hematoxyline and eosin staining. The result of UUOinduced model is the production of massive scar formation of glomeruli cells observed in the positive control group. These fibrotic changes in UUO injured kidney was remarkably abrogated by NNSEE and standard drug, indicating antifibrotic activity. Collectively, these data suggest that the NNSEE treatment improves the long-term outcome of injured kidney by ameliorating renal fibrosis. Doxorubicin-induced kidney injury can lead to progressive renal fibrosis. The presented study, Hematoxyline and Eosin staining was used to assess tubular damage or tubular necorosis occurring in the kidney. The doxorubicin-induced model produced massive tubular damage in the positive control group. These fibrotic changes in doxorubicin-induced kidney was remarkably abrogated by NNSEE and the standard drug, indicating anti-fibrotic activity. Collectively, these data suggest that the NNSEE treatment improves the long-term outcome of injured kidney by ameliorating renal fibrosis.
HISTOPATHOLOGICAL STUDIES
Histopathology of UUO induced renal fibrosis
Histopathology of doxorubicin-induced renal fibrosis
DISCUSSION
In the presented study it was observed that the treatment by NNSEE exerted beneficial effects on renal fibrosis induced with Doxorubicin and Unilateral Ureter Obstruction (UUO) models. The results showed that the accumulation of fibrocytes, hyalinization of glomeruli in the kidney was evidently suppressed by NNSEE treatment. The possible underlying mechanism might be its inhibition of renal expression of TGF-β 1 and MCP-1 chemoattractants contributing to the fibrocytes recruitment into the injured kidney [8] .
Renal fibrosis underlies all forms of end-stage renal disease. It is the inevitable consequence of an excessive accumulation of extracellular matrix that occurs in virtually every type of chronic kidney disease [9]. The incidence of chronic kidney disease leading to end-stage renal disease (ESRD) continues to increase worldwide. Almost all forms of ESRD are preceded by the progressive appearance of renal fibrosis. Currently, treatment of renal fibrosis is severely limited and often ineffective [10, 11] . During the past decade, many drugs have been introduced onto the market for the management of renal fibrosis; their effectiveness, however, was unequivocal among the entire range of the population suffering from this renal disorder. Although most of these medications are safe and efficacious, in some patients prolonged usage may have questionable efficacy and cause disabling side-effects. This fact initiates the development of anti-fibrosis drugs derived from herbal sources and which have a better rate of success, ability to achieve full remission, with minimal incidence of side-effects. Alternative treatments using herbal medicines are therefore of great interest. The use of herbal medicines is now widespread for the treatment of various disease and disorders. The presented study focused on a most common and chronic disease -renal fibrosis, and its treatment using herbal extracts from a traditionally used herbal plant -Nelumbo nucifera.
A study was therefore designed to evaluate the anti-fibrosis activity in kidney by using NNSEE. Nelumbo nucifera is a herbaceous, aquatic plant of the Nelumbonaceae family, native to Tropical Asia and Queensland, Australia. It has been used in folk medicine and has been proved to have anti-obesity, anti-diabetic, anti-fertility, hepatoprotective, pulmonary protective, anti-parkinsonism, anti-bacterial, anti-oxidant, anti-platelet, anti-wrinkle, cytoprotective, analgesic, anti-proliferative and anti-inflammatory properties [12] . It is also used in the management of fibrosis but its pharmacological mechanism on renal fibrosis remains unknown. Through ongoing investigation in this area, the authors of the presented study found that the Nelumbo nucifera seed has anti-fibrotic activity in kidney, although this is not yet been proved scientifically.
Preliminary phytochemical investigations (Tab. 1) of NNSEE has showed positive results to alkaloids, saponins, tannins, flavonoids, carbohydrates, proteins and amino acids. The presence of these biochemical constituents may show better therapeutic action to renal fibrosis [13] . An acute toxicity study for NNSEE was conducted as per OECD Guidelines 423 by using Wistar albino rats. Each group of animals treated with the NNSEE solution by the oral route did not result in signs or symptoms of acute toxicity or mortality within 24 hours and a further period for 14 days. The obtained data on toxicity studies of NNSEE (Tab. 2) did not show any lethality (LD 50 ) in rats weighing up to 2,000mg/kg. According to the OECD guidelines, a safe dose range, i.e. 1/5 (400mg/kg b.wt) as test-2 dose and 1/10 (200mg/kg b.wt) as test-1 dose, was used for subsequent studies [14] . Moreover, the selection of the animal model may depend on the progression of the disease, since some models develop renal fibrosis rapidly, e.g. ureteral obstruction model (1-2 weeks), while others take several weeks, e.g. doxorubicin, Anti-Thy1 or protein overload induced nephropathy. Furthermore, reproducibility in the level of disease is an important criterion in choosing the animal model. In the current study it was noted that UUO and Doxorubicin-inducing methods are used mostly as models for inducing fibrotic activity. Other methods are very complicated and time-consuming processes for inducing disease. Therefore, in this study, the two abovementioned methods of inducing the disease were selected and investigated.
Unilateral Ureter Obstruction (UUO).
This model is characterized by tissue loss, atrophy of tubular epithelial cells and development of tubulointerstitial inflammation 200g) . After treatment, the biochemical parameters like serum creatinine(Graph 5), BUN level attenuates (Graph 6), total protein(Graph 7) and GFR levels were elevated (Graph 8) in UUO-induced renal fibrosis. This revealed that the NNSEE test-2 (400mg/kg b.wt) showed a greater effect than the test-1 (200mg/kg b.wt), which indicates anti-fibrotic activity and is a potently dose dependent.
Doxorubicin or Adriamycin-induced nephropathy.
This model is characterized by the development of proteinuria, focal segmental glomerulosclerosis and tubulointerstitial fibrosis. It mimics the proteinuric condition in patients, and is considered an experimental analogue of human focal glomerulosclerosis. Doxorubicin is an anti-neoplastic agent and causes nephrotoxicity through many mechanisms, such as by inducing oxidative stress and by affecting water and urea transporters in the renal medulla.
In the presented study, renal fibrosis was well established within 1-2 months of a single intravenous injection of doxorubicin (4mg/kg b.wt). Doxorubicin plays a major role in deterioration of the glomerular structure, proteinuria, tubular and interstitial inflammation, culminating renal fibrosis in rats. Biochemical parameters were evaluated, e.g. serum creatinine (Graph 1), BUN levels were elevated (Graph 2), while total protein (Graph 3) [17] and GFR levels were decreased (Graph 4); tubular cell necrosis in doxorubicininduced renal fibrosis After two months, rats were treated with the standard drug (Pirfenidone 200mg/kg b.wt, p.o) and NNSEE at a dose of 200 and 400mg/kg b.wt p.o. NNSEE ameliorated all the profibrotic responses. After treatment, NNSEE and pirfenidone reversed all the manifestations of renal fibrosis. NNSEE test-2 (400mg/kg b.wt) showed a better therapeutic effect than the test-1 (200mg/kg b.wt), which indicates anti-fibrotic activity and is potently dose dependent.
Antioxidants naturally present in the body play a role in preventing the development of free radicals and inhibit the oxidation of other molecules. Oxidation is a chemical reaction that can produce free radicals, leading to chain reactions that may damage cells. Cells are protected against oxidative stress by an interacting network of antioxidant enzymes [18] . Antioxidant enzymes, e.g. SOD, CAT and peroxidases, are the major enzymes which prevent free radicals. SOD is present in almost all aerobic cells and in extracellular fluids. In humans, SOD is present in cytosol and mitochondrion, and also exists in extracellular fluids. SOD catalyzes the breakdown of the superoxide anion (free radical) into oxygen and hydrogen peroxide [19] . CAT is mainly present in peroxisomes which catalyze the conversion of hydrogen peroxide to oxygen and water by using iron or manganese cofactors [20] . Peroxidases also catalyze the reduction of hydrogen peroxides [21] .
In the current study, the antioxidant activity of Superoxide dismutase (SOD) and Catalase (CAT) was estimated. Oxidative stress is produced by doxorubicin which induces glomerular toxicity in rats. Redox cycling of the quinone Table 3 . Evaluation of Serum creatinine, BUN, Total protein and GFR levels in doxorubicin induced group functional group doxorubicin is proposed as the key factor in doxorubicin nephrotoxicity. Reactive oxygen species (ROS) may initiate a degenerative cascade by the oxidation of cellular thiols and lipid membrane structures. Doxorubicin has been suggested to upregulate NADPH-oxidase (NOX), an important source of ROS in the kidney [22] . The generated reactive oxygen species, such as superoxide and hydroxyl radicals, have the potential to cause damage to various intracellular components. A deficiency of oxygen supply may destroy the tubular cells and glomerular cells in kidney that leads to one of the reason for renal fibrosis. SOD activity (Graph 9) decreases in renal fibrosis-induced animals due to excessive formation of superoxide free radicals, and also the activities of scavenging enzyme CAT (Graph10) significantly.
UUO-induced and doxorubicin-induced animals showed a significant reduction of Superoxide dismutase (SOD) and Catalase (CAT) enzymes, compared to the normal group of rats. Elevated reactive oxygen species may prompt the disease. The induced animals were treated with NNSEE at a dose of 200 and 400mg/kg b.wt which reversed all these manifestations after the experimental period. This may be due to the presence of polyphenols and alkaloids in the NNSEE which have an antioxidant property and nephroprotective potential in a dose dependent manner. The test-2 (400mg/kg) of NNSEE showed a more potent therapeutic activity than the test-1 (200mg/kg).
In the histopathology of kidney tissue, it was clearly noted that hyalinization of glomeruli, degenerative changes, tubular damage, vacuolization and necrosis took place, which all led to renal fibrosis [23] . Rats were then treated with the NNSEE, as well as the standard drug Pirfenidone, which ameliorated all the profibrotic responses, the regeneration of glomerular cells took place, and excess hyalinalized glomeruli decreased. NNSEE of test-2 (400mg/kg b.wt) showed better therapeutic activity than the test-1 (200mg/kg b.wt) in a dose dependent manner, which may be due mainly to the presence of alkaloids and polyphenols.
Hence, the presented study shows that NNSEE has an anti-fibrotic property in kidney by altering the profibrotic responses, and also showed antioxidant property by increasing SOD and CAT levels, which may be due to the presence of constituents (alkaloids and polyphenols) present in the Nelumbo nucifera seed. These results suggest that NNSEE could be effective in reversing the profibrotic responses in renal fibrosis. The test-2 (400mg/kg) of NNSEE showed greater therapeutic effect than the test-1 (200mg/kg).
CONCLUSION
This research on renal fibrosis using doxorubicin and UUOinducing models strongly implies that the over-production of hyalinized glomeruli may be due to the activation of TGF-β, which causes repeated tissue injury leading to renal fibrosis. NNSEE ameliorates renal fibrosis by inhibiting the recruitment of fibrocytes into the kidney, and influences antioxidant and anti-fibrotic activity. This substantiates the therapeutic utility in renal fibrosis. The results obtained suggest that NNSEE might be a potential agent to be applied in clinics for preventing the progression of renal fibrosis in a dose dependent manner. Further studies are needed to investigate the role of NNSEE in other models of renal fibrosis, such as subtotal nephrectomy, renal ischemia, and Anti-Thy1 antibody for the exact biochemical constituents responsible for anti-fibrotic activity.
